4503 — Astellas Pharma Cashflow Statement
0.000.00%
HealthcareConservativeLarge CapHigh Flyer
- ¥4tn
- ¥4tn
- ¥2tn
- 98
- 28
- 82
- 83
Annual cashflow statement for Astellas Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 248,967 | 245,350 | 145,324 | 156,886 | 132,361 |
Depreciation | |||||
Non-Cash Items | 6,391 | 12,437 | 91,075 | 73,650 | 85,167 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -61,917 | -102,186 | -2,208 | -52,777 | 4,501 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 256,899 | 221,997 | 306,843 | 257,443 | 327,767 |
Capital Expenditures | -52,128 | -77,888 | -77,441 | -76,448 | -88,541 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 10,371 | -311,905 | -4,453 | 14,035 | 4,041 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -41,757 | -389,793 | -81,894 | -62,413 | -84,500 |
Financing Cash Flow Items | -1,173 | -847 | -2,268 | -2,530 | -3,217 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -233,681 | 181,055 | -229,479 | -216,298 | -195,623 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -20,657 | 7,317 | 7,737 | -10,143 | 60,854 |